A rare case of amoebic liver abscess as an immediate post-COVID-19 complication in an immunocompetent female: our experience from KIMS Secunderabad


  • Praveen Kumar Kulkarni Department of Internal Medicine, Krishna Institute of Medical Sciences (KIMS), Secunderabad, Telangana, India
  • Vinay Kumar Department of Internal Medicine, Krishna Institute of Medical Sciences (KIMS), Secunderabad, Telangana, India
  • Daya Vaswani Department of Cardiology, Nizam Institute of Medical Sciences (NIMS), Hyderabad, Telangana, India
  • Anant A. Takalkar Department of Community Medicine, MIMSR Medical College and YCRH, Latur, Maharashtra, India




Amoebic liver abscess, COVID 19, SARS-CoV-2


The coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, the capital city of the Hubei Province, China, in late 2019. It was declared a pandemic by the World Health Organization on March 11th, 2020(1). COVID-19 has challenged healthcare systems through its highly infectious nature and case fatality rate. Till date, numerous complications of COVID-19 have been reported including post COVID-19 Lung fibrosis, pulmonary thromboembolism, lung abscess, complications involving other organs apart from respiratory system like Acute coronary syndromes, Takotsubo cardiomyopathy, peripheral thromboembolic events, large vessel strokes, vasculitis. Direct hepatic injury or hepatitis has also been reported. But there is sparsity of data on occurrence of liver abscess as an immediate post COVID 19 complication. Hence, we present this case of a middle-aged immunocompetent female to highlight the importance of considering rare complications in COVID 19 patients.


Othman N, Mohamed Z, Yahya MM, Leow VM, Lim BH, Noordin R. Entamoeba histolytica antigenic protein detected in pus aspirates from patients with amoebic liver abscess. Exp Parasitol. 2013;134(4):504-10.

Czerwonko ME, Huespe P, Bertone S, Pellegrini P, Mazza O, Pekolj J et al. Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. HPB (Oxford). 2016;18(12):1023-30.

Lardière-Deguelte S, Ragot E, Amroun K, Piardi T, Dokmak S, Bruno O et al. Hepatic abscess: Diagnosis and management. J Visc Surg. 2015;152(4):231-43.

Sánchez Thevenet P, Alvarez HM, Torrecillas C, Jensen O, Basualdo JA. Dispersion of Echinococcus granulosus eggs from infected dogs under natural conditions in Patagonia, Argentina. J Helminthol. 2019;94:e29.

Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004;2(11):1032-8.

Singh A, Banerjee T, Kumar R, Shukla SK. Prevalence of cases of amebic liver abscess in a tertiary care centre in India: A study on risk factors, associated microflora and strain variation of Entamoeba histolytica. PLoS One. 2019;14(4):e0214880.

Ghosh S, Sharma S, Gadpayle AK, Gupta HK, Mahajan RK, Sahoo R et al. Clinical, laboratory, and management profile in patients of liver abscess from northern India. J Trop Med. 2014;2014:142382.

Lal T, Iyyappan RP, Kaliyappa C. Is There a Difference in Etiology in the Liver Abscesses in South India? A Clinical and Microbiological Study. MAMC J Med Sci. 2020;6(3):225-7.

World Health Organization. WHO coronavirus (COVID-19. Available at: www. Who.int. (Accessed on 20 August 2021.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Shaobo S, Mu Q, Bo S, Yuli C, Tao L, Fan Y et al. Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10

Chaomin Wu, Xiaoyan C, Yanping C, Jia’an X, Xing Z, Sha X et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43.

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382(21):2012-22.

Wander P, Epstein M, Bernstein D. COVID-19 Presenting as Acute Hepatitis. Am J Gastroenterol. 2020;115(6):941-2.

Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428-30.

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517-20.

Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529-30.

Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C et al. Pulmonary arterial thrombosis in covid-19 with fatal outcome. Ann Internal Med. 2020;173(5):350-61.

Lagana SM, Kudose S, Iuga AC. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol. 2020;33:2147-55.

Du C, Shao S, Ai W, Zhang H. A case of novel coronavirus pneumonia complicated with liver abscess. Bachu Med. 2020;3(2):11-4.

Dutta S. 'Unusually large' liver abscess found in 14 Covid-19 recovered patients in Delhi. 2021: 1-5.

Dhadiala SK, Whatkar AA. Rare case of Liver Abscess in COVID 19 Positive. Int J Current Res. 2021;13(06):17932-4.






Case Reports